284 related articles for article (PubMed ID: 37488596)
41. Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.
de Vries E; Mazzetti M; Takkenberg B; Mostafavi N; Bikker H; Marzioni M; de Veer R; van der Meer A; Doukas M; Verheij J; Beuers U
Liver Int; 2020 Dec; 40(12):3042-3050. PubMed ID: 32893960
[TBL] [Abstract][Full Text] [Related]
42. ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations Associated with Cholestasis with Different Phenotypes and Outcomes.
Al-Hussaini A; Lone K; Bashir MS; Alrashidi S; Fagih M; Alanazi A; AlYaseen S; Almayouf A; Alruwaithi M; Asery A
J Pediatr; 2021 Sep; 236():113-123.e2. PubMed ID: 33915153
[TBL] [Abstract][Full Text] [Related]
43. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
Jacquemin E; De Vree JM; Cresteil D; Sokal EM; Sturm E; Dumont M; Scheffer GL; Paul M; Burdelski M; Bosma PJ; Bernard O; Hadchouel M; Elferink RP
Gastroenterology; 2001 May; 120(6):1448-58. PubMed ID: 11313315
[TBL] [Abstract][Full Text] [Related]
44. Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications.
Yeap SP; Harley H; Thompson R; Williamson KD; Bate J; Sethna F; Farrell G; Hague WB
J Gastroenterol Hepatol; 2019 Feb; 34(2):425-435. PubMed ID: 29992621
[TBL] [Abstract][Full Text] [Related]
45. Familial intrahepatic cholestasis: New and wide perspectives.
Vitale G; Gitto S; Vukotic R; Raimondi F; Andreone P
Dig Liver Dis; 2019 Jul; 51(7):922-933. PubMed ID: 31105019
[TBL] [Abstract][Full Text] [Related]
46. The Multiple Facets of ABCB4 (MDR3) Deficiency.
Sundaram SS; Sokol RJ
Curr Treat Options Gastroenterol; 2007 Dec; 10(6):495-503. PubMed ID: 18221610
[TBL] [Abstract][Full Text] [Related]
47. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.
Chen HL; Wu SH; Hsu SH; Liou BY; Chen HL; Chang MH
J Biomed Sci; 2018 Oct; 25(1):75. PubMed ID: 30367658
[TBL] [Abstract][Full Text] [Related]
48. Progressive familial intrahepatic cholestasis with high gamma-glutamyltranspeptidase levels in Taiwanese infants: role of MDR3 gene defect?
Chen HL; Chang PS; Hsu HC; Lee JH; Ni YH; Hsu HY; Jeng YM; Chang MH
Pediatr Res; 2001 Jul; 50(1):50-5. PubMed ID: 11420418
[TBL] [Abstract][Full Text] [Related]
49. First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.
Pasmant E; Goussard P; Baranes L; Laurendeau I; Quentin S; Ponsot P; Consigny Y; Farges O; Condat B; Vidaud D; Vidaud M; Chen JM; Parfait B
Eur J Hum Genet; 2012 Mar; 20(3):277-82. PubMed ID: 21989363
[TBL] [Abstract][Full Text] [Related]
50. A novel heterozygous deletion in ABCB4 gene in a Chinese family with intrahepatic cholestasis of pregnancy, neonatal hyperbilirubinemia, and cholelithiasis: Case reports and literature review.
Zheng Y; Rao Q; Han Y; He J
Mol Genet Genomic Med; 2024 Jan; 12(1):e2291. PubMed ID: 37787087
[TBL] [Abstract][Full Text] [Related]
51. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.
de Vree JM; Jacquemin E; Sturm E; Cresteil D; Bosma PJ; Aten J; Deleuze JF; Desrochers M; Burdelski M; Bernard O; Oude Elferink RP; Hadchouel M
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):282-7. PubMed ID: 9419367
[TBL] [Abstract][Full Text] [Related]
52. Current and future therapies for inherited cholestatic liver diseases.
van der Woerd WL; Houwen RH; van de Graaf SF
World J Gastroenterol; 2017 Feb; 23(5):763-775. PubMed ID: 28223721
[TBL] [Abstract][Full Text] [Related]
53. A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis.
Küçükçongar Yavaş A; Çavdarlı B; Ünal Uzun Ö; Uncuoğlu A; Gündüz M
J Pediatr Endocrinol Metab; 2020 May; 33(5):665-669. PubMed ID: 32229667
[TBL] [Abstract][Full Text] [Related]
54. A New Variant of an Old Itch: Novel Missense Variant in
Shankar S; Pande A; Geetha TS; Raichurkar K; Sakpal M; Lochan R; Asthana S
J Clin Exp Hepatol; 2022; 12(2):701-704. PubMed ID: 35535055
[TBL] [Abstract][Full Text] [Related]
55. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
56. Molecular overview of progressive familial intrahepatic cholestasis.
Amirneni S; Haep N; Gad MA; Soto-Gutierrez A; Squires JE; Florentino RM
World J Gastroenterol; 2020 Dec; 26(47):7470-7484. PubMed ID: 33384548
[TBL] [Abstract][Full Text] [Related]
57. Combined features of low phospholipid-associated cholelithiasis and progressive familial intrahepatic cholestasis 3.
Poupon R; Barbu V; Chamouard P; Wendum D; Rosmorduc O; Housset C
Liver Int; 2010 Feb; 30(2):327-31. PubMed ID: 19840255
[TBL] [Abstract][Full Text] [Related]
58. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
[TBL] [Abstract][Full Text] [Related]
59. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
Vitale G; Gitto S; Raimondi F; Mattiaccio A; Mantovani V; Vukotic R; D'Errico A; Seri M; Russell RB; Andreone P
J Gastroenterol; 2018 Aug; 53(8):945-958. PubMed ID: 29238877
[TBL] [Abstract][Full Text] [Related]
60. Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in
Wang R; Sheps JA; Liu L; Han J; Chen PSK; Lamontagne J; Wilson PD; Welch I; Borchers CH; Ling V
J Lipid Res; 2019 Jan; 60(1):85-97. PubMed ID: 30416103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
